Global Health Limited (MEDANTA) - Net Assets
Based on the latest financial reports, Global Health Limited (MEDANTA) has net assets worth Rs37.10 Billion INR (≈ $401.24 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs54.10 Billion ≈ $585.02 Million USD) and total liabilities (Rs16.99 Billion ≈ $183.78 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Global Health Limited (MEDANTA) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs37.10 Billion |
| % of Total Assets | 68.59% |
| Annual Growth Rate | 15.74% |
| 5-Year Change | 145.06% |
| 10-Year Change | N/A |
| Growth Volatility | 15.24 |
Global Health Limited - Net Assets Trend (2018–2025)
This chart illustrates how Global Health Limited's net assets have evolved over time, based on quarterly financial data. Also explore Global Health Limited asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Global Health Limited (2018–2025)
The table below shows the annual net assets of Global Health Limited from 2018 to 2025. For live valuation and market cap data, see MEDANTA market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs33.88 Billion ≈ $366.35 Million |
+16.59% |
| 2024-03-31 | Rs29.06 Billion ≈ $314.23 Million |
+19.66% |
| 2023-03-31 | Rs24.28 Billion ≈ $262.60 Million |
+50.26% |
| 2022-03-31 | Rs16.16 Billion ≈ $174.77 Million |
+16.90% |
| 2021-03-31 | Rs13.82 Billion ≈ $149.50 Million |
+2.43% |
| 2020-03-31 | Rs13.50 Billion ≈ $145.95 Million |
+1.40% |
| 2019-03-31 | Rs13.31 Billion ≈ $143.93 Million |
+9.34% |
| 2018-03-31 | Rs12.17 Billion ≈ $131.64 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Global Health Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 251.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs22.48 Billion | 66.40% |
| Common Stock | Rs537.17 Million | 1.59% |
| Other Comprehensive Income | Rs121.79 Million | 0.36% |
| Other Components | Rs10.72 Billion | 31.66% |
| Total Equity | Rs33.86 Billion | 100.00% |
Global Health Limited Competitors by Market Cap
The table below lists competitors of Global Health Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Legend Biotech Corp
NASDAQ:LEGN
|
$3.25 Billion |
|
Enerjisa Enerji AS
IS:ENJSA
|
$3.25 Billion |
|
Beijing BDStar Navigation Co Ltd
SHE:002151
|
$3.25 Billion |
|
KB Home
NYSE:KBH
|
$3.25 Billion |
|
Navan, Inc. Class A Common Stock
NASDAQ:NAVN
|
$3.24 Billion |
|
Towne Bank
NASDAQ:TOWN
|
$3.24 Billion |
|
Ningxia Orient Tantalum Industry Co Ltd
SHE:000962
|
$3.24 Billion |
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
$3.24 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Global Health Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 29,056,270,000 to 33,864,100,000, a change of 4,807,830,000 (16.5%).
- Net income of 4,814,370,000 contributed positively to equity growth.
- New share issuances of 12,660,000 increased equity.
- Other comprehensive income decreased equity by 74,670,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs4.81 Billion | +14.22% |
| Share Issuances | Rs12.66 Million | +0.04% |
| Other Comprehensive Income | Rs-74.67 Million | -0.22% |
| Other Changes | Rs55.47 Million | +0.16% |
| Total Change | Rs- | 16.55% |
Book Value vs Market Value Analysis
This analysis compares Global Health Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.86x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 23.14x to 8.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-03-31 | Rs48.28 | Rs1117.25 | x |
| 2019-03-31 | Rs51.50 | Rs1117.25 | x |
| 2020-03-31 | Rs53.65 | Rs1117.25 | x |
| 2021-03-31 | Rs54.84 | Rs1117.25 | x |
| 2022-03-31 | Rs64.03 | Rs1117.25 | x |
| 2023-03-31 | Rs93.59 | Rs1117.25 | x |
| 2024-03-31 | Rs108.17 | Rs1117.25 | x |
| 2025-03-31 | Rs126.05 | Rs1117.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Global Health Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.22%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.04%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 1.41x
- Recent ROE (14.22%) is above the historical average (8.46%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 2.70% | 2.40% | 0.69x | 1.63x | Rs-888.49 Million |
| 2019 | 3.96% | 3.56% | 0.58x | 1.91x | Rs-782.47 Million |
| 2020 | 2.69% | 2.45% | 0.56x | 1.98x | Rs-986.27 Million |
| 2021 | 2.08% | 2.02% | 0.53x | 1.95x | Rs-1.09 Billion |
| 2022 | 12.14% | 9.05% | 0.69x | 1.95x | Rs345.97 Million |
| 2023 | 13.43% | 12.10% | 0.65x | 1.70x | Rs832.58 Million |
| 2024 | 16.46% | 14.60% | 0.76x | 1.48x | Rs1.88 Billion |
| 2025 | 14.22% | 13.04% | 0.77x | 1.41x | Rs1.43 Billion |
Industry Comparison
This section compares Global Health Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $19,140,946,444
- Average return on equity (ROE) among peers: 5.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Global Health Limited (MEDANTA) | Rs37.10 Billion | 2.70% | 0.46x | $3.25 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $25.19 Billion | 8.42% | 0.70x | $11.87 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $31.90 Billion | 8.43% | 1.35x | $3.92 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.48 Billion | 20.14% | 0.55x | $122.84 Million |
| Healthcare Global Enterprises Limited (HCG) | $4.90 Billion | 4.52% | 1.50x | $873.06 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.88 Billion | 17.73% | 2.15x | $869.25 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $5.67 Billion | -8.43% | 0.98x | $2.89 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $509.11 Million | -4.42% | 0.10x | $26.73 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $93.81 Billion | 11.47% | 0.62x | $10.45 Billion |
| Max India Limited (MAXIND) | $4.92 Billion | -11.45% | 0.39x | $88.24 Million |
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emerg… Read more